Navigation Links
U.S. Physician Prescribing Behavior Impacted by Health Insurance Exchanges and Accountable Care Organizations

BURLINGTON, Mass., Oct. 24, 2013 /PRNewswire/ -- Decision Resources Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that pharmaceutical companies are facing a paradigm shift in the way their brands gain access to the U.S. market, as Accountable Care Organizations (ACOs) continue to develop across the nation and enrollment on the health insurance exchanges moves forward.

"Through our comprehensive surveys of physicians and MCO executives, we're able to see how the enormous changes in the U.S. healthcare market are affecting pharmaceutical brands.  When we looked at currently available and emerging brands by therapy, it was clear that some will benefit and others will be challenged," said Roy Moore, Senior Director at Decision Resources, a Decision Resources Group company. "For instance, looking at schizophrenia and depression, physician and payer responses suggest constrained use of branded therapies on exchange-based plans because of generic competition—even though they feel Abilify and Cymbalta will remain popular therapies. In light of the new dynamics shaping reimbursement decisions, pharmaceutical brand teams looking forward to 2014 vs. backward to 2013 will be crafting market access strategies that take changes like these into account."

ACOs, of which there are more than 500 across the US, will also impact prescribing behavior and brand uptake across therapies. For example, half of surveyed pulmonologists who participate in an ACO reduced their prescribing of the branded leukotriene inhibitor Singulair—while one-third assigned more of their patients to montelukast, a generic form of the same drug favored by ACO policies such as co-pay reductions. Similarly, 43% report they are less likely to prescribe Dulera because of their participation in an ACO whereas only 13% report increased prescribing of this agent. Yet the findings show that ACOs did not universally push physicians to generics—pulmonologists are evenly split in whether they increased or decreased prescribing of Advair (a competing combination therapy), highlighting how a brand can withstand the challenges stemming from new reimbursement models.

About Physician & Payer Forum Reports—2013 "Physician & Payer Dynamics" SeriesU.S. Physician & Payer Forum is the industry's only syndicated primary market research product that includes insights from both physicians and HMO/PPO pharmacy directors to get a true sense of how both parties shape a market. The 2013 "Physician & Payer Dynamics" Series investigates how novel payer-led care coordination and financing programs impact prescribing behavior.  The Series helps pharmaceutical brand managers and marketers develop effective market access strategies within the new paradigms brought about by Healthcare Reform. Find out more here.

2013 "Physician & Payer Dynamics" Report Titles:

  • NEW Healthcare Reform: Impact of Expanding Role for Medicaid and Health Exchanges on Prescribing of Schizophrenia, Bipolar Disorder and Unipolar Depression Drugs
  • NEW Payer Strategies and Access: Narrow Networks, Employed Physicians and Provider Consolidation's Impact on Prescribing Decisions for Cardiologists – Acute Coronary Syndrome and Post-Hospital Atrial Fibrillation
  • NEW Impact of Payer-Imposed Strategies on Market Access in NSCLC and Prostate Cancer: Clinical Pathways, Bundled Payments and Accountable Care Organization Contracting
  • NEW Market Access for High-Cost Brands in Multiple Sclerosis, Oncology, and Rheumatoid Arthritis
  • NEW Accountable Care Organizations: How Will Payer and Provider Adoption of this Model Impact Prescribing Trends in Asthma and COPD?
  • E-Prescribing and Electronic Health Records: Impact of Technology on Prescribing for Hypertension and Diabetes
  • About Decision Resources Group
    Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:  Lydia Smith

    Elizabeth MarshallDecision Resources Group

    Decision Resources Group 781-993-2594


    SOURCE Decision Resources Group
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Physician-Patient Alliance for Health & Safety: Maternal Morbidity on the Rise and Likely to Climb Even Higher
    2. KemPharm Forms Physician Advisory Council Advocating "Intelligent Pain Therapeutic Development"
    3. Dr. Michael Feiz on What Makes a Great Bariatric Physician
    4. Market Disruption Imminent as Hospitals and Physicians Aggressively Adopt Patient Portal Technology
    5. CMTC announces Physician Collaboration Platform ("PCP") Upgrade: A cloud-based telehealth solution for improved collaboration, access and performance
    6. Lack of Formulary Access Tops List of Limitations Primary Care Physicians Face With e-Prescribing Systems, Says New Research Report from SciMedica Group MR&C
    7. inVentiv Health Clinical Launches Physician Network For Late-Stage Research
    8. Unique Glaucoma Test Through Eyelid DIATON Opens Doctors Eyes to Possibility of In-Office Glaucoma Test at Pri-Med East and American Academy of Family Physicians, AAFP
    9. Update: 2013 List of Best Doctors in Dallas Features Texas Institute for Surgery Physicians
    10. 2013 List of Best Doctors in Dallas Features Texas Institute for Surgery Physicians
    11. Childhood Obesity Need Not Last a Lifetime, says Beverly Hills Physicians
    Post Your Comments:
    (Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
    (Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
    (Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
    Breaking Medicine Technology:
    (Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
    (Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
    (Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
    (Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
    (Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
    Breaking Medicine News(10 mins):